Table 3 Peritoneal and systemic recurrence rates* during study period according to T stages in curatively resected patients.

From: Interleukin 10 level in the peritoneal cavity is a prognostic marker for peritoneal recurrence of T4 colorectal cancer

 

Number of patients during study period

Pt’s with ascites

T stage

T0

T1

T2

T3

T4

Total

T4

Recurrence†

(n = 33)

(n = 105)

(n = 89)

(n = 451)

(n = 97)

(n = 775)

(n = 62‡)

PR

(−)

33

103

89

435

70

730

44

(+)

0

2

0

16

27

45

18

% PR(+)

0

1.9

0

3.5

27.8

5.8

29.0

SR

(−)

33

99

87

372

72

663

42

PR(−) in SR(−)

33

99

87

369

59

647

34

PR(+) in SR(−)

0

0

0

3

13

16

8

% PR(+) in SR(−)

0

0

0

0.8

18.1

2.4

19.0

( +)

0

6

2

79

25

112

19

PR(−) in SR(+)

0

4

2

66

11

83

9

PR(+) in SR(+)

0

2

0

13

14

29

10

% PR (+) in SR (+)

 

33.3

0

16.5

56.0

25.9

52.6

% SR

0

5.71

2.25

17.5

25.8

14.5

31.1

  1. *Recurrence of patients excluding palliative resection, preoperative chemo- or radiotherapy, retroperitoneal rectal cancer, M1c stage, operative mortality and follow up less than 1 month regardless of ascites harvest.
  2. †PR: peritoneal recurrence; SR: systemic recurrence.
  3. ‡One patient with ascites but without IL10 data was included.
Back to article page